Sale!

Immunohistochemistry Single Marker with Interpretation Test

Original price was: $112.Current price is: $88.

-21%

The Immunohistochemistry Single Marker with Interpretation Test is a specialized diagnostic procedure that uses antibody-based staining to detect specific protein markers in tissue samples. This advanced testing method helps identify cancer types, determine tumor characteristics, and guide personalized treatment strategies. By analyzing the presence and distribution of specific biomarkers, healthcare providers can make more accurate diagnoses and select targeted therapies. The test is particularly valuable for distinguishing between different cancer subtypes, predicting treatment response, and assessing prognosis. At just $88 USD, this essential diagnostic tool provides critical information for cancer management decisions. Our expert pathologists provide comprehensive interpretation of results, ensuring you receive clear, actionable insights for your healthcare journey.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Immunohistochemistry Single Marker with Interpretation Test

Comprehensive Introduction to Immunohistochemistry Testing

Immunohistochemistry (IHC) Single Marker testing represents a cornerstone of modern cancer diagnostics, providing crucial insights into tumor biology and treatment planning. This sophisticated laboratory technique utilizes specific antibodies to detect and visualize particular protein markers within tissue samples, offering unprecedented precision in cancer characterization. The integration of expert interpretation ensures that patients and healthcare providers receive clinically relevant, actionable information to guide treatment decisions.

The importance of IHC testing cannot be overstated in contemporary oncology practice. By identifying specific molecular markers, this test helps transform generic cancer diagnoses into personalized treatment pathways, ultimately improving patient outcomes and quality of life. The single marker approach allows for focused analysis of clinically significant biomarkers, providing targeted information that directly influences therapeutic choices.

What the Test Measures and Detects

The Immunohistochemistry Single Marker test specifically identifies and localizes individual protein antigens within tissue specimens through antibody-antigen interactions. This sophisticated detection system provides critical information about:

  • Specific protein expression patterns within tumor cells
  • Cellular localization of biomarkers (nuclear, cytoplasmic, or membrane)
  • Intensity and distribution of marker expression throughout the tissue
  • Presence or absence of clinically relevant biomarkers
  • Quantitative assessment of marker expression levels

Common markers analyzed include hormone receptors (ER/PR), HER2/neu, Ki-67 proliferation index, p53 tumor suppressor protein, and various cytokeratins, among others. Each marker provides unique insights into tumor behavior and potential treatment responses.

Who Should Consider This Test

Immunohistochemistry Single Marker testing is recommended for patients in several clinical scenarios:

Diagnostic Indications

  • Patients with newly diagnosed cancer requiring precise classification
  • Individuals with metastatic disease of unknown primary origin
  • Cases where routine histopathology provides inconclusive results
  • Patients being evaluated for targeted therapy eligibility

Symptomatic Presentations

  • Unexplained masses or tumors requiring characterization
  • Suspected malignancies needing definitive diagnosis
  • Recurrent cancers requiring updated biomarker assessment
  • Patients with treatment-resistant disease

Significant Benefits of Immunohistochemistry Testing

Choosing Immunohistochemistry Single Marker testing provides numerous advantages for comprehensive cancer care:

Diagnostic Precision

  • Accurate tumor classification beyond routine histology
  • Definitive identification of cancer subtypes
  • Enhanced diagnostic confidence for challenging cases
  • Reduced diagnostic uncertainty and misclassification

Therapeutic Guidance

  • Personalized treatment selection based on biomarker profiles
  • Prediction of treatment response to specific therapies
  • Identification of targeted therapy opportunities
  • Optimization of chemotherapy and radiation regimens

Prognostic Value

  • Assessment of disease aggressiveness and behavior
  • Prediction of recurrence risk and metastatic potential
  • Monitoring of treatment effectiveness over time
  • Guidance for surveillance intensity and frequency

Understanding Your Test Results

Our comprehensive interpretation provides clear, clinically relevant insights into your immunohistochemistry results:

Result Interpretation Framework

  • Positive Results: Indicate presence of the specific biomarker, which may guide targeted treatment approaches or confirm diagnostic suspicions
  • Negative Results: Absence of the marker, which can help exclude certain diagnoses or indicate alternative treatment pathways
  • Variable Expression: Mixed or heterogeneous staining patterns that may require additional clinical correlation
  • Intensity Scoring: Quantitative assessment of marker expression strength, often reported on standardized scales

Clinical Correlation

Our expert pathologists provide detailed interpretation that integrates your IHC results with clinical history, imaging findings, and other laboratory data. This comprehensive approach ensures that results are placed in appropriate clinical context, maximizing their utility for treatment planning and patient management.

Test Pricing and Details

Test Component Price (USD)
Immunohistochemistry Single Marker with Interpretation Test $112 USD
Discount Price $88 USD

Additional Test Information

  • Turnaround Time: 10 days from sample receipt
  • Sample Requirements: Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block
  • Shipping Instructions: Ship at room temperature with proper documentation
  • Required Documentation: Histopathology report, biopsy site information, and complete clinical history

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas. Our network includes specialized facilities in:

  • New York City – Manhattan and surrounding boroughs
  • Los Angeles – Multiple locations throughout Southern California
  • Chicago – Downtown and suburban testing centers
  • Houston – Comprehensive cancer diagnostic services
  • Phoenix – State-of-the-art laboratory facilities
  • Philadelphia – Expert pathology consultation available
  • San Antonio – Advanced immunohistochemistry capabilities
  • San Diego – Cutting-edge diagnostic technology
  • Dallas – Rapid turnaround times maintained
  • San Jose – Silicon Valley precision diagnostics

Additional testing locations are available in numerous other cities throughout the United States, ensuring accessible cancer diagnostic services for all patients.

Take Control of Your Cancer Diagnosis Today

Don’t leave your cancer diagnosis to chance. The Immunohistochemistry Single Marker test provides the critical information needed to make informed treatment decisions and optimize your cancer care journey. Our team of expert pathologists and oncology specialists are ready to provide the precise diagnostic information you need.

Call or WhatsApp us now at +1(267) 388-9828 to schedule your test or speak with our clinical specialists. We’re available to answer your questions, discuss testing requirements, and help you understand how immunohistochemistry can benefit your specific situation.

Take the first step toward personalized cancer care with advanced diagnostic testing that makes a difference in treatment outcomes and quality of life. Your journey to precise diagnosis and targeted treatment begins with a single phone call.